PT  - JOURNAL ARTICLE
AU  - Mehdi Djekidel
AU  - Ghulam Syed
AU  - Aladdin Kanbour
TI  - Imaging Biomarkers in Lung Cancer with <sup>68</sup>Ga-DOTATATE, <sup>18</sup>F-Fluoride, and <sup>18</sup>F-FDG PET/CT Scans and the Theranostics Paradigm
AID  - 10.2967/jnmt.120.258343
DP  - 2021 Sep 01
TA  - Journal of Nuclear Medicine Technology
PG  - 281--283
VI  - 49
IP  - 3
4099  - http://tech.snmjournals.org/content/49/3/281.short
4100  - http://tech.snmjournals.org/content/49/3/281.full
SO  - J. Nucl. Med. Technol.2021 Sep 01; 49
AB  - Lung cancer is the number 1 cause of cancer deaths in the United States. The prognosis is quite grim with the exception of stage 1. When faced with several failed therapeutic regimens and rapid progression of the disease, considering alternative therapies such as radiopharmaceutical therapies may be an option. We describe the case of a 36-y-old man with lung adenocarcinoma who had imaging molecular characterization of his disease with 18F-FDG, 68Ga-DOTATATE, and 18F-fluoride PET/CT scans that were able to shed some light on molecular characterization of his disease and serve as a guide to potential targeted or personalized radiopharmaceutical therapeutic options.